Intravenous tenecteplase found beneficial from 4.5 to 24 hours after non-large vessel occlusion ischemic stroke

For patients with non-large vessel occlusion, acute ischemic stroke and salvageable brain tissue, intravenous tenecteplase administered 4.5 to 24 hours after stroke onset is associated with a higher likelihood of excellent functional outcome at…

Continue Reading

News Source: medicalxpress.com